Exact Mass: 455.1639

Exact Mass Matches: 455.1639

Found 46 metabolites which its exact mass value is equals to given mass value 455.1639, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5,10-Methenyltetrahydrofolic acid

(6aR)-8-(4-{[(1S)-1,3-dicarboxypropyl]-C-hydroxycarbonimidoyl}phenyl)-1-hydroxy-3-imino-3H,4H,5H,6H,6aH,7H-8lambda5-imidazo[1,5-f]pteridin-8-ylium

C20H21N7O6 (455.1553)


Folate is important for cells and tissues that rapidly divide. Cancer cells divide rapidly, and drugs that interfere with folate metabolism are used to treat cancer. Methotrexate is a drug often used to treat cancer because it inhibits the production of the active form, tetrahydrofolate. Unfortunately, methotrexate can be toxic, producing side effects such as inflammation in the digestive tract that make it difficult to eat normally. Folinic acid is a form of folate that can help rescue or reverse the toxic effects of methotrexate. Folinic acid is not the same as folic acid. Folic acid supplements have little established role in cancer chemotherapy. There have been cases of severe adverse effects of accidental substitution of folic acid for folinic acid in patients receiving methotrexate cancer chemotherapy. It is important for anyone receiving methotrexate to follow medical advice on the use of folic or folinic acid supplements. Low concentrations of folate, vitamin B12, or vitamin B6 may increase your level of homocysteine, an amino acid normally found in your blood. There is evidence that an elevated homocysteine level is an independent risk factor for heart disease and stroke. The evidence suggests that high levels of homocysteine may damage coronary arteries or make it easier for blood clotting cells called platelets to clump together and form a clot. However, there is currently no evidence available to suggest that lowering homocysteine with vitamins will reduce your risk of heart disease. Clinical intervention trials are needed to determine whether supplementation with folic acid, vitamin B12 or vitamin B6 can lower your risk of developing coronary heart disease. Methylene tetrahydrofolate (CH2FH4) is formed from tetrahydrofolate by the addition of methylene groups from one of three carbon donors: formaldehyde, serine, or glycine. Methyl tetrahydrofolate(CH3FH4) can be made from methylene tetrahydrofolate by reduction of the methylene group, and formyl tetrahydrofolate (CHOFH4, folinic acid) is made by oxidation of methylene tetrahydrofolate. In the form of a series of tetrahydrofolate compounds, folate derivatives are substrates in a number of single-carbon-transfer reactions, and also are involved in the synthesis of dTMP (2-deoxythymidine-5-phosphate) from dUMP (2-deoxyuridine-5-phosphate). It helps convert vitamin B12 to one of its coenzyme forms and helps synthesize the DNA required for all rapidly growing cells.

   

(4S)-4-[[4-(3-Amino-1-oxo-5,6,6a,7-tetrahydro-2H-imidazo[1,5-f]pteridin-10-ium-8-yl)benzoyl]amino]-5-hydroxy-5-oxopentanoate

(4S)-4-[[4-(3-Amino-1-oxo-5,6,6a,7-tetrahydro-2H-imidazo[1,5-F]pteridin-10-ium-8-yl)benzoyl]amino]-5-hydroxy-5-oxopentanoic acid

C20H21N7O6 (455.1553)


   

N-(6-Amino-2-methyl-pyridin-3-ylmethyl)-2-(6-methyl-2-oxo-3-phenylmethanesulfonylamino-2H-pyridin-1-yl)-acetamide

N-[(6-Imino-2-methyl-1,6-dihydropyridin-3-yl)methyl]-2-[6-methyl-2-oxo-3-(phenylmethanesulphonamido)-1,2-dihydropyridin-1-yl]ethanimidic acid

C22H25N5O4S (455.1627)


   

N-Formylmethionyl-methionyl-phenylalanine

2-{[1-hydroxy-2-({1-hydroxy-2-[(hydroxymethylidene)amino]-4-(methylsulphanyl)butylidene}amino)-4-(methylsulphanyl)butylidene]amino}-3-phenylpropanoic acid

C20H29N3O5S2 (455.1549)


   

N-Pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide

N-(pyridazin-3-yl)-4-[(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)methylidene]piperidine-1-carboxamide

C23H20F3N5O2 (455.1569)


Redafamdastat (PF-04457845) is a highly efficacious and selective FAAH inhibitor with IC50 values is 7.2±0.63 nM and 7.4±0.62 nM for hFAAH and rFAAH, respectively.

   

2-[[4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid

2-[(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]-5-methoxy-5-oxopentanoic acid

C20H21N7O6 (455.1553)


   

2-[[4-[(2-Amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-4-methylpentanedioic acid

2-[(4-{[(4-hydroxy-2-imino-1,2-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]-4-methylpentanedioate

C20H21N7O6 (455.1553)


   

5,10-methylenetetrahydrofolate

4-Carboxy-4-[(4-{3-imino-1-oxido-3H,4H,5H,6H,6ah,7H,8H,9H-imidazo[1,5-F]pteridin-8-yl}phenyl)formamido]butanoic acid

C20H21N7O6 (455.1553)


5,10-methylenetetrahydrofolate is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 5,10-methylenetetrahydrofolate can be found in a number of food items such as yellow bell pepper, mexican groundcherry, celery leaves, and hard wheat, which makes 5,10-methylenetetrahydrofolate a potential biomarker for the consumption of these food products. The diastereoisomer [6R]-5,10-methylene-THF is the key endogenous one-carbon donor and a co-substrate of the TS (thymidylate synthase) enzyme for methylation of 2-deoxy-uridine-5-monophosphate (dUMP) to 2-deoxy-thymidine-5-monophosphate (dTMP). The coenzyme is necessary for the biosynthesis of thymidine and is the C1-donor in the reactions catalyzed by TS and thymidylate synthase (FAD) .

   
   
   

Maybridge1_006740

Maybridge1_006740

C27H25N3O2S (455.1667)


   

5,10-Methenyltetrahydrofolate

5,10-Methenyltetrahydrofolate

C20H21N7O6 (455.1553)


   

N5,N10-Methenyltetrahydrofolic acid

N5,N10-Methenyltetrahydrofolic acid

C20H21N7O6 (455.1553)


   

16-carboxy-Delta(13)-17,18,19,20-tetranor-N-acetyl-leukotriene E4

(5Z,7E,9E,11R,12S)-11-(N-acetyl-L-cystein-S-yl)-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid;(5Z,7E,9E,11R,12S)-11-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-12-hydroxyhexadeca-3,5,7,9-tetraenedioic acid

C21H29NO8S (455.1614)


   

Methopterin

2-[[4-[(2-Amino-4-Oxo-1H-Pteridin-6-Yl)Methyl-Methylamino]Benzoyl]Amino]Pentanedioic Acid

C20H21N7O6 (455.1553)


   

(2S)-2-[[(2S)-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-phenylpropanoic acid

(2S)-2-[[(2S)-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-phenylpropanoic acid

C20H29N3O5S2 (455.1549)


   

1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]-1-propanone

1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]-1-propanone

C29H26ClNO2 (455.1652)


   

13H-spiro[benzo[c]indeno[2,1-a]carbazole-14,9-fluorene]

13H-spiro[benzo[c]indeno[2,1-a]carbazole-14,9-fluorene]

C35H21N (455.1674)


   

Moxifloxacin hydrochloride monohydrate

Moxifloxacin hydrochloride monohydrate

C21H27ClFN3O5 (455.1623)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones D004791 - Enzyme Inhibitors

   

5,10-Methylenetetrahydrofolate(2-)

5,10-Methylenetetrahydrofolate(2-)

C20H21N7O6-2 (455.1553)


   

Allyl-{6-[3-(4-bromo-phenyl)-1-methyl-1H-indazol-6-YL]oxy}hexyl)-N-methylamine

Allyl-{6-[3-(4-bromo-phenyl)-1-methyl-1H-indazol-6-YL]oxy}hexyl)-N-methylamine

C24H30BrN3O (455.1572)


   

3-(2-Chlorophenyl)-1-(2-{[(1S)-2-hydroxy-1,2-dimethylpropyl]amino}pyrimidin-4-YL)-1-(4-methoxyphenyl)urea

3-(2-Chlorophenyl)-1-(2-{[(1S)-2-hydroxy-1,2-dimethylpropyl]amino}pyrimidin-4-YL)-1-(4-methoxyphenyl)urea

C23H26ClN5O3 (455.1724)


   

5,10-Methylene-6-hydrofolic acid

5,10-Methylene-6-hydrofolic acid

C20H21N7O6 (455.1553)


   

N-Formylmethionyl-methionyl-phenylalanine

2-{[1-hydroxy-2-({1-hydroxy-2-[(hydroxymethylidene)amino]-4-(methylsulphanyl)butylidene}amino)-4-(methylsulphanyl)butylidene]amino}-3-phenylpropanoic acid

C20H29N3O5S2 (455.1549)


   

(6R)-5,10-methylenetetrahydrofolate(2-)

(6R)-5,10-methylenetetrahydrofolate(2-)

C20H21N7O6-2 (455.1553)


   

2-[[4-(3-Amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl)benzoyl]amino]pentanedioate

2-[[4-(3-Amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl)benzoyl]amino]pentanedioate

C20H21N7O6-2 (455.1553)


   

(Rs)-5,10-methenyltetrahydrofolate

(Rs)-5,10-methenyltetrahydrofolate

C20H21N7O6 (455.1553)


   

4-(2-amino-3-cyano-5-oxo-5,6,7,8-tetrahydro-4H-chromen-4-yl)-2,6-dimethoxyphenyl morpholine-4-carboxylate

4-(2-amino-3-cyano-5-oxo-5,6,7,8-tetrahydro-4H-chromen-4-yl)-2,6-dimethoxyphenyl morpholine-4-carboxylate

C23H25N3O7 (455.1692)


   
   

(6R)-5,10-methylenetetrahydrofolate(2-)

(6R)-5,10-methylenetetrahydrofolate(2-)

C20H21N7O6 (455.1553)


   

5,10-Methylenetetrahydrofolate(2-)

5,10-Methylenetetrahydrofolate(2-)

C20H21N7O6 (455.1553)


   
   

AD57

AD57

C22H20F3N7O (455.1681)


AD57 is an orally active multikinase inhibitor, inhibits RET, BRAF, S6K and Src, with greatly reduces mTOR activity[1].

   

(1s,6r,10r,12r,19s,20r,21s)-21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione

(1s,6r,10r,12r,19s,20r,21s)-21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione

C24H25NO8 (455.158)


   

[(2r,3r,4r,5s,6r)-2-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-2-{[(2s)-1-hydroxy-3-oxopropan-2-yl]oxy}-6-methyloxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]amino acetate

[(2r,3r,4r,5s,6r)-2-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-2-{[(2s)-1-hydroxy-3-oxopropan-2-yl]oxy}-6-methyloxan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]amino acetate

C17H29NO13 (455.1639)


   

[2-({4,5-dihydroxy-2-[(1-hydroxy-3-oxopropan-2-yl)oxy]-6-methyloxan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]amino acetate

[2-({4,5-dihydroxy-2-[(1-hydroxy-3-oxopropan-2-yl)oxy]-6-methyloxan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]amino acetate

C17H29NO13 (455.1639)


   

(2e,4e)-n-[(3s)-7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid

(2e,4e)-n-[(3s)-7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid

C23H31Cl2NO4 (455.163)


   

3-[({10-amino-10-benzyl-7,9,10a-trihydroxy-3-oxo-1h,2h,5h-pyrrolo[1,2-b]isoquinolin-5-yl}(hydroxy)methylidene)amino]propanoic acid

3-[({10-amino-10-benzyl-7,9,10a-trihydroxy-3-oxo-1h,2h,5h-pyrrolo[1,2-b]isoquinolin-5-yl}(hydroxy)methylidene)amino]propanoic acid

C23H25N3O7 (455.1692)


   

(1's,14'r)-1'-{[(4s)-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-13'-oxa-8',11'-diazaspiro[cyclopropane-1,10'-tetracyclo[6.5.1.0²,⁷.0¹¹,¹⁴]tetradecane]-2',4',6'-trien-9'-one

(1's,14'r)-1'-{[(4s)-3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl]methyl}-13'-oxa-8',11'-diazaspiro[cyclopropane-1,10'-tetracyclo[6.5.1.0²,⁷.0¹¹,¹⁴]tetradecane]-2',4',6'-trien-9'-one

C25H21N5O4 (455.1593)


   

21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione

21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione

C24H25NO8 (455.158)


   

(2e,4e,6r)-n-[(2s,3s)-7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid

(2e,4e,6r)-n-[(2s,3s)-7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid

C23H31Cl2NO4 (455.163)


   

(2s)-3-acetyl-2-aminopentanedioic acid; bis(oxindole)

(2s)-3-acetyl-2-aminopentanedioic acid; bis(oxindole)

C23H25N3O7 (455.1692)


   

(2e,4e)-n-{7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl}-4,6-dimethyldodeca-2,4-dienimidic acid

(2e,4e)-n-{7,9-dichloro-2-hydroxy-8-oxo-1-oxaspiro[4.5]deca-6,9-dien-3-yl}-4,6-dimethyldodeca-2,4-dienimidic acid

C23H31Cl2NO4 (455.163)


   

(1r,6r,10r,12r,19r,20s,21r)-21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione

(1r,6r,10r,12r,19r,20s,21r)-21-(dimethylamino)-16,20-dihydroxy-12,19-dimethyl-7,11,23-trioxahexacyclo[17.3.1.0²,¹⁸.0³,¹⁵.0⁵,¹³.0⁶,¹⁰]tricosa-2,5(13),15,17-tetraene-4,8,14-trione

C24H25NO8 (455.158)


   

1'-({3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-13'-oxa-8',11'-diazaspiro[cyclopropane-1,10'-tetracyclo[6.5.1.0²,⁷.0¹¹,¹⁴]tetradecane]-2',4',6'-trien-9'-one

1'-({3-hydroxy-6-oxo-1h,4h-pyrazino[2,1-b]quinazolin-4-yl}methyl)-13'-oxa-8',11'-diazaspiro[cyclopropane-1,10'-tetracyclo[6.5.1.0²,⁷.0¹¹,¹⁴]tetradecane]-2',4',6'-trien-9'-one

C25H21N5O4 (455.1593)